Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide—a drug known as Zepbound—on weight loss with respect to energy expenditure, fat oxidation and calorie intake.
This article was originally published on MedicalXpress.com